Css LLC Moderna, Inc. Call Options Transaction History

Css LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $2.82 Million - $5 Million	-23,800 Reduced 86.55%	3,700 $664,000
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $1.77 Million - $2.91 Million	15,000 Added 120.0%	27,500 $3.25 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $234,260 - $353,180	-2,000 Reduced 13.79%	12,500 $1.79 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $1.01 Million - $1.88 Million	8,000 Added 123.08%	14,500 $2.5 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $16.9 Million - $36.9 Million	-76,100 Reduced 92.13%	6,500 $2.5 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $4.49 Million - $8.13 Million	34,600 Added 72.08%	82,600 $19.4 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $3.47 Million - $5.91 Million	31,800 Added 196.3%	48,000 $6.29 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $407,587 - $1.05 Million	6,200 Added 62.0%	16,200 $1.69 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $592,306 - $1.03 Million	-10,900 Reduced 52.15%	10,000 $708,000
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $371,602 - $660,022	20,900 New	20,900 $627,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.